Weight loss injections in South Africa: the complete guide

What are weight loss injections?

Weight loss injections are medicines from a class called GLP-1 receptor agonists, plus one dual-hormone medicine that adds a second target called GIP. They copy hormones your gut releases after eating, which tell the brain you are full and slow how fast the stomach empties.

The result is a smaller appetite and less hunger between meals, which lowers how much you eat over time. They are injected into the fat just under the skin, not into muscle or a vein, using a pre-filled pen. This class is often called GLP-1 treatment, and it is the same family of medicine used for type 2 diabetes.

Which weight loss injections are available in South Africa?

Four injectable medicines are available in South Africa in 2026. The table sums up the differences; individual results vary for every figure, and each weight-loss average comes from a trial where people also changed diet and activity.

Two points on that table. Ozempic is registered for diabetes, not weight, so its weight figure comes from the higher 2.4 mg dose of the same molecule sold as Wegovy. And Mounjaro gained its weight-management approval in October 2025, having launched for diabetes in December 2024. For a closer look at three of these side by side, see Saxenda vs Ozempic vs Mounjaro.

Are weight loss injections in stock in South Africa?

Mostly yes, with branch-level gaps. The global supply crunch of 2023 and 2024 has eased, and in 2026 all four injections are stocked by Dischem, Clicks and independent community pharmacies. What still runs short is specific strengths of specific products at specific branches, because demand concentrates on the middle doses people hold for months.

Three practical rules. Phone the dispensary before you travel. Ask the pharmacy to order if your strength is out, which most can do within a day or two. And never stretch or double doses to bridge a gap without speaking to the doctor managing your plan, because a schedule can usually be adjusted safely around a shortage.

One thing a shortage never changes is the price: South Africa's Single Exit Price system fixes each medicine's price nationally, so surge pricing is unlawful. Sellers who appear during shortages with stock at strange prices are dealt with in the counterfeit section below. Product-by-product availability detail sits in is Mounjaro available in South Africa and Saxenda in South Africa.

How do weight loss injections work?

All four act on the GLP-1 receptor, a hormone signal released after meals. Activating it slows stomach emptying, reduces appetite and helps you feel full sooner. Mounjaro adds a second signal, GIP, which is why it is called a dual-action medicine and one reason it produced larger average weight loss in trials.

The effect is on appetite, not on metabolism directly. You eat less because you feel full on less food, and that calorie reduction, kept up over months, is what drives the weight change. This is why every one of these medicines is registered for use alongside diet and activity changes, not instead of them. To understand the two semaglutide brands in this list, read is Wegovy available in South Africa and Ozempic in South Africa.

How much weight can you lose with them?

Trial averages give the clearest guide, and they differ by medicine. Every figure below is a trial average alongside diet and activity changes, and individual results vary.

• Saxenda (liraglutide 3.0 mg): about 8% of body weight over 56 weeks in the SCALE trial.
• Wegovy (semaglutide 2.4 mg): about 15% over 68 weeks in the STEP-1 trial.
• Mounjaro (tirzepatide): 15% on 5 mg, 19.5% on 10 mg and 20.9% on 15 mg over 72 weeks in SURMOUNT-1.

Averages are not promises. Some people lose more than the average, some less, and a minority respond very little. Response is checked over the first months, and if the medicine is not helping, a doctor reviews the plan rather than simply pushing the dose.

How much do weight loss injections cost in South Africa?

Prices differ by medicine, dose and pharmacy. The figures below are publicly reported 2026 ranges, given as market information only. We do not sell medicine. Prices vary by pharmacy and dose; confirm with your pharmacy.

The medicine is not the only cost. A realistic monthly budget also includes doctor consultations, any baseline blood tests and follow-up reviews as the dose changes. For the full breakdown, see GLP-1 weight loss cost in South Africa.

Medical aid schemes generally do not fund weight-management medicine, because obesity is not a Prescribed Minimum Benefit condition. Some schemes fund these medicines for type 2 diabetes under chronic benefits, and scheme positions change year by year, so check your own plan's rules.

Who are weight loss injections for?

The registered use across these medicines is for adults with a BMI of 30 or more, or 27 or more with at least one weight-related condition such as high blood pressure, high cholesterol, type 2 diabetes or obstructive sleep apnoea. BMI is a screening number, not the full picture.

A doctor also weighs up your medical history, current medicines, previous weight-loss attempts and any contraindications before deciding whether treatment is clinically appropriate. These medicines are not registered for cosmetic weight loss, for people in a healthy weight range, or for anyone under 18. They are also not a first step: diet, activity and behaviour change stay at the base of any plan, with medicine added where that foundation is not enough on its own.

What are the side effects and risks?

All four share the same main side effects, because they act on the same gut-hormone system: nausea, diarrhoea, constipation, vomiting and indigestion. These are usually mild to moderate, most noticeable when the dose increases, and tend to settle as the body adjusts. Slower dose increases, smaller meals and staying hydrated all help. Our guide to GLP-1 side effects and how to manage them covers this in detail.

None of these medicines suits everyone. They should not be used in pregnancy or while breastfeeding, or by people with a personal or family history of medullary thyroid cancer or MEN2 syndrome. A history of pancreatitis or gallbladder problems needs careful discussion with a doctor. Severe, persistent stomach pain can be a sign of pancreatitis: seek medical care immediately. People who take insulin or a sulfonylurea need closer monitoring because of the risk of low blood sugar.

How do you store and travel with injection pens?

All four injections share the same cold-chain rules. Unopened pens stay in the fridge at 2 to 8 degrees Celsius and must never freeze: a pen that has frozen must be discarded, because freezing destroys the active ingredient without any visible change.

Once a pen is in use, each product allows a limited spell out of the fridge below 30 degrees Celsius, stated in its patient leaflet. The Mounjaro KwikPen, for example, may be kept below 30 degrees for up to 30 days after first use, according to Lilly. Check your own product's leaflet rather than borrowing another product's rule.

Load shedding is manageable. A closed fridge holds a safe temperature for a few hours, so short outages need nothing but a shut door. For longer outages, a cooler box with ice packs works, with the pen wrapped in a cloth so it never touches the packs directly. If you are unsure after a long outage, ask your pharmacist before injecting.

For travel: pens fly in hand luggage only, never in checked baggage, because the cargo hold can dip below freezing. Use a small cooler pouch, keep the original pharmacy-labelled packaging, and carry a doctor's letter for international trips. In summer, never leave a pen in a parked car. Technique away from home stays the same, covered in how to inject GLP-1 medicines.

Can you switch from one injection to another?

Yes, people switch between these injections, and a doctor manages every version of the change. The common triggers are side effects that will not settle, a results plateau, persistent stock problems with one product, or budget pressure at a higher dose.

The mechanics matter more than people expect. Doses never transfer directly between medicines: the new medicine starts at its own starting dose and climbs its own ladder, because the molecules differ in potency and schedule. Timing follows the old medicine: after a weekly injection, the new one typically starts about a week after the last dose, while after daily Saxenda the changeover is quicker. No washout period is required for these switches.

Expect the adjustment period to repeat at the new starting dose: appetite effects and mild digestive symptoms often return briefly, then settle. The molecule comparison sits in semaglutide vs tirzepatide. The right option is decided by a doctor on assessment.

How do you avoid counterfeit weight loss injections?

The one-check rule: a genuine weight loss injection reaches you only through a licensed pharmacy, against a doctor-confirmed treatment plan. Any seller that skips the doctor, whether a website, a social media account or a messaging contact, is not selling a registered product.

SAHPRA has warned the public repeatedly about falsified, compounded and substandard products in this class circulating online. These copies are not evaluated for safety, quality or efficacy, their contents are unverified, and compounded semaglutide or tirzepatide has no SAHPRA registration in any form.

What genuine product looks like: it arrives cold from a pharmacy fridge, sealed in the manufacturer's packaging with a batch number and expiry date, and the dispensing pharmacy is one you can verify with the South African Pharmacy Council. A price far below published levels is a warning, not a bargain.

Report suspicious sellers to SAHPRA's 24-hour hotline on 0800 204 307. The online-buying question gets a full answer in can you buy Ozempic online legally and safely.

Can you get weight loss injections at public hospitals?

No. In 2026 no weight loss injection is stocked in South Africa's public sector, so government hospitals and clinics cannot supply them. Access runs through private doctors and private pharmacies, which puts cost at the centre of the national debate.

Policy is moving, slowly. Spotlight reports that the National Essential Medicines List Committee is prioritising a review of this class for the public sector list, and the World Health Organization added four of these medicines to its Model List of Essential Medicines in September 2025, followed by a global guideline on their use in obesity in December 2025.

The need is not small: around 28% of South African adults live with obesity, and researchers estimate millions would meet treatment criteria. Generic competition, which began with SAHPRA's approval of the first generic semaglutide in July 2026, is widely expected to pull published prices down over the next few years.

Are weight loss injections a long-term treatment?

Yes, and both the budget and the plan work better when you treat them that way from the start. Trials across the class show that weight tends to return when treatment stops, which is why South African and international guidance frames obesity as a chronic condition managed over years, not a short course corrected in a season.

That has two practical consequences. Financially, the realistic planning unit is a year of medicine, consultations and reviews, not a single month. Clinically, the habits built during treatment carry the long-term result: the eating pattern in what to eat on GLP-1 medication and the training approach in exercise and GLP-1 results both compound the medicine's effect and protect the result if treatment ever pauses.

Stopping is its own clinical decision, made with a doctor rather than declared at the pharmacy counter. The full picture, including what the trials show about regain and how to defend a result, is in maintaining weight loss after GLP-1.

How does prescribing work in South Africa?

Because all of these are Schedule 4 medicines, the clinical process is the same everywhere: a doctor assesses a patient's health, weight history and goals. Where treatment is clinically appropriate, the doctor confirms a treatment plan, and a licensed pharmacy dispenses the medicine. No legitimate pharmacy dispenses these without a doctor's authorisation.

The assessment can happen at any GP practice or through a doctor-led telehealth service. It checks blood pressure, medical history, current medicines and contraindications first, then sets a starting dose. Follow-up reviews matter just as much, because the dose steps up over the first months and side effects need managing along the way. For the wider view of this medicine class in the country, see GLP-1 in South Africa.

Frequently asked questions